Prostaglandin E2 receptor 4 (EP4) is a prostaglandin receptor for prostaglandin E2 (PGE2) encoded by the PTGER4 gene in humans. It is one of four identified EP receptors, the others being EP1, EP2, and EP3, all of which bind with and mediate cellular responses to PGE2 and also, but generally with lesser affinity and responsiveness, certain other prostanoids (see Prostaglandin receptors). EP4 has been implicated in various physiological and pathological responses in animal models and humans.
Based on the Prostaglandin E2 Receptor EP4 Subtype market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Prostaglandin E2 Receptor EP4 Subtype market covered in Chapter 5:
Eli Lilly
Eisai Inc
AskAt
Kaken Pharmaceutical
Ono Pharmaceutical
Rottapharm Biotech
In Chapter 6, on the basis of types, the Prostaglandin E2 Receptor EP4 Subtype market from 2015 to 2025 is primarily split into:
KAG-308
CR 6086
ONO 4232
ONO 4578
E 7046
EP4-R Antagonist
AAT 008
In Chapter 7, on the basis of applications, the Prostaglandin E2 Receptor EP4 Subtype market from 2015 to 2025 covers:
Cancer
Autoimmune Disease
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Prostaglandin E2 Receptor EP4 Subtype. Industry analysis & Market Report on Prostaglandin E2 Receptor EP4 Subtype is a syndicated market report, published as Global Prostaglandin E2 Receptor EP4 Subtype Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Prostaglandin E2 Receptor EP4 Subtype market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.